In this article, we are going to discuss the 10 best global stocks to buy according to Wall Street analysts.
International equities outperformed the US stock market in 2025. Investing experts say several factors are still supporting overseas markets in 2026, including a weaker US dollar, geopolitical shifts, and heavy concentration in domestic tech stocks in recent years.
Tim Seymour, Seymour Asset Management chief investment officer, said on January’s CNBC’s “ETF Edge” that the structural underweight many US investors have toward global markets is now acting as a tailwind. He pointed out that while international equities make up about 30–40% of global market capitalization, US investors’ exposure is closer to 12–15% at the higher end, and often even lower.
Experts say spreading a portfolio across a wide range of assets helps ensure that one part is always “working,” which can smooth returns over time. Foreign stocks have gone through long dry periods before. Still, history shows they can lead US markets for extended stretches, as seen in the latter half of the 1980s and much of the early 2000s, based on data from Hartford Funds.
In terms of current market activity, CNBC reported on April 21 that global stocks have recovered losses linked to the Iran conflict. Major indexes are now trading at or above pre-war levels, as investors unwind geopolitical risk hedges and shift focus back to the artificial intelligence theme, according to market watchers. The MSCI World Index, which tracks more than 1,000 large- and mid-cap stocks across developed markets, dropped 3.29% in the week following the start of the Middle East war. In recent days, it has reached a new record high and is now nearly 2% above its March 2 level, the first trading session after the conflict began.
Given this, we will take a look at some of the best global stocks.
Image by Steve Buissinne from Pixabay
Our Methodology
To collect data for this article, we used our screeners to find companies that are headquartered outside of the United States but are traded on US exchanges. We limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. The following are the Best Global Stocks to Buy According to Analysts.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
10. Eni S.p.A (NYSE:E)
Upside Potential as of April 20: 16.06%
Eni S.p.A. (NYSE:E) operates as an integrated energy company in Italy, the rest of Europe, the United States, Asia, Africa, and internationally.
Eni S.p.A. (NYSE:E) announced on April 20 that it had made a “giant” natural gas discovery in the Ganal block offshore Indonesia, with preliminary estimates indicating resources of approximately 5 trillion cubic feet of gas and 300 million barrels of condensate.
The discovery was made at the Geliga-1 exploration well, drilled to a total depth of around 5,100 meters in a water depth of about 2,000 meters. The discovery is among the five exploration wells that Eni S.p.A. (NYSE:E) drilled over the last six months within the same basin. The find could help increase the Italian energy giant’s gas output in Indonesia to 2,000 million standard cubic feet per day in 2028, from around 700 million standard cubic feet per day currently.
Eni S.p.A. (NYSE:E) continues to invest in Indonesia and revealed last month that it had reached a final investment decision for the development of two more major deepwater gas projects in the country.
9. Sanofi (NASDAQ:SNY)
Upside Potential as of April 20: 16.69%
Sanofi (NASDAQ:SNY) is a healthcare biopharmaceutical company that engages in the research, development, manufacture, and marketing of therapeutic solutions.
On April 20, BNP Paribas analyst Peter Verdult downgraded Sanofi (NASDAQ:SNY) from ‘Outperform’ to ‘Neutral’, while assigning the stock a price target of $50. The firm cited its revised pipeline assumptions for the downgrade, noting that a “near-term rerating story is unlikely”.
On the other hand, Citi analyst Graham Parry turned slightly more bullish on Sanofi (NASDAQ:SNY) earlier on April 13, raising the firm’s price target on the stock from €80 to €82 (read more details here).
Sanofi (NASDAQ:SNY) projects its sales to grow by a high single-digit percentage in FY 2026, with business EPS surging slightly faster than sales. The company expects this profitable growth to continue for at least five years. Additionally, Sanofi plans to execute a share buyback program of €1B this year.
The strong guidance comes despite Sanofi (NASDAQ:SNY) undergoing a significant change in top leadership this month, with Belén Garijo taking charge as the company’s new CEO on April 29.
